Published Date: 17 Jul 2025
Children living near nuclear power stations in the U.K. are not at increased risk of childhood cancers, according to a new analysis.
Read Full NewsImproving Diabetic Macular Edema Care in Native American Communities: Real-World Insights and Culturally Responsive Approaches
Targeting the PI3K/AKT/PTEN Pathway to Optimize Treatment for HR+/HER2- Breast Cancer
Navigating Treatment-Associated Adverse Events and Patient-Centered Supportive Care in HR+/HER2- Breast Cancer
Optimizing Safe Administration of Novel Infusion Therapies in HR+/HER2- Advanced Breast Cancer
Optimizing Treatment Sequencing in Endocrine-Refractory HR+/HER2- Breast Cancer
Evaluating the Latest Evidence on Emerging Somatostatin Receptor Ligands for Acromegaly
Navigating Advances in Cystic Fibrosis Care
1.
Study: One-week breast cancer radiotherapy proven as safe and effective as standard three-week treatment
2.
In advanced endometrial cancer, immunocheckpoint inhibitor-chemotherapy combination improves overall survival.
3.
First-Line Combination for Bladder Cancer Not Eligible for Cisplatin Just Misses Positive Outcome.
4.
AI Unlocks Benefits of Prostate Cancer Treatment.
5.
Q&A: How early cancer screening could save Canada nearly half a billion dollars over patients' lifetimes
1.
From Diagnosis to Recovery: A Comprehensive Guide to Dealing with Cystic Teratoma
2.
The Bloodstream Compass: A Comparative Clinical Review of Liquid Biopsy and AI in Predictive Oncology
3.
Obesity is a major risk factor for cancer
4.
Managing High Potassium Levels: A Comprehensive Guide to Veltassa
5.
Understanding Acute Myeloid Leukemia (AML) and Its Survival Rates
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option
2.
The Era of Targeted Therapies for ALK+ NSCLC: A Paradigm Shift
3.
Advances in Classification/ Risk Stratification of Plasma Cell Dyscrasias- The Summary
4.
A Continuation to The Evolving Landscape of First-Line Treatment for Urothelial Carcinoma
5.
Navigating the Complexities of Ph Negative ALL - Part IV
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation